Alpha Profiles · Company Profile

aTYR PHARMA INC

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/atyr-pharma-inc

Entity: Public listing published
Primary listing: NASDAQ: ATYR
Verification: Partially verified
Last reviewed: 2026-09-18T04:46:53.169804+00:00

Overview

Alpha's canonical identity and public leadership record for aTYR PHARMA INC.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

3 public records

Jill M. Broadfoot

Chief Financial Officer

State: confirmed
Effective: From Mar 26, 2026
Confidence: 94%
Evidence: ATYR DEF 14A executive officersMar 26, 2026

Nancy E. Denyes

General Counsel and Corporate Secretary

State: confirmed
Effective: From Mar 26, 2026
Confidence: 94%
Evidence: ATYR DEF 14A executive officersMar 26, 2026

Sanjay S. Shukla, M.D., M.S.

President, Chief Executive Officer and Director

State: confirmed
Effective: From Mar 26, 2026
Confidence: 94%
Evidence: ATYR DEF 14A executive officersMar 26, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 18, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.